Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajesh Krishna

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Clinical and Translational Science|September 24, 2020
Enabling Warp Speed Using the Hypervelocity Innovation Model: A Blue Print for Drug Development in PandemicsRajesh Krishna
Journal of Clinical Pharmacology|April 3, 2026
Beyond Impossibility: Reimagining Clinical Evidence for Children with Ultra-Rare DiseasesRajesh Krishna
Journal of Clinical Pharmacology|September 1, 2009
Model-based evaluation of QTc interval risk: an increasing emphasis on early decision makingRajesh Krishna
Journal of Pharmacokinetics and Pharmacodynamics|April 27, 2023
Special issue: Model-informed drug development in rare diseases: connecting the dots in an information rich ecosystemRajesh Krishna
Journal of Clinical Pharmacology|November 11, 2025
US FDA's Strategic Transition of Animal to Non-Animal Alternatives for Monoclonal Antibody Development: A Much Needed Fuel to Incentivize InnovationRajesh Krishna
Drug Discovery Today|April 12, 2026
Strategic adoption of model-informed drug development (MIDD) as an overarching business model in biotechnology and life science industryRajesh Krishna
Journal of Clinical Pharmacology|May 11, 2020
The Clinical Pharmacology Sections in Drug Package Inserts: Do We Need to Reexamine the Basis?Rajesh Krishna
Journal of Clinical Pharmacology|May 19, 2021
Is QTc the Right Surrogate in Adequately Assessing the Risk for TdP for Development Compound Candidates? A Call to InvestigateRajesh Krishna
Journal of Clinical Pharmacology|August 22, 2006
Quantitative clinical pharmacology: Making paradigm shifts a realityRajesh Krishna
Journal of Clinical Pharmacology|November 27, 2025
Has Pharmacologic Contextualization Become a Lost Art? How Can We Revive the Integrator Pharmacologist?Rajesh Krishna
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Clinical and Translational Science|September 24, 2020
Enabling Warp Speed Using the Hypervelocity Innovation Model: A Blue Print for Drug Development in PandemicsRajesh Krishna
Journal of Clinical Pharmacology|April 3, 2026
Beyond Impossibility: Reimagining Clinical Evidence for Children with Ultra-Rare DiseasesRajesh Krishna
Journal of Clinical Pharmacology|September 1, 2009
Model-based evaluation of QTc interval risk: an increasing emphasis on early decision makingRajesh Krishna
Journal of Pharmacokinetics and Pharmacodynamics|April 27, 2023
Special issue: Model-informed drug development in rare diseases: connecting the dots in an information rich ecosystemRajesh Krishna
Journal of Clinical Pharmacology|November 11, 2025
US FDA's Strategic Transition of Animal to Non-Animal Alternatives for Monoclonal Antibody Development: A Much Needed Fuel to Incentivize InnovationRajesh Krishna
Drug Discovery Today|April 12, 2026
Strategic adoption of model-informed drug development (MIDD) as an overarching business model in biotechnology and life science industryRajesh Krishna
Journal of Clinical Pharmacology|May 11, 2020
The Clinical Pharmacology Sections in Drug Package Inserts: Do We Need to Reexamine the Basis?Rajesh Krishna
Journal of Clinical Pharmacology|May 19, 2021
Is QTc the Right Surrogate in Adequately Assessing the Risk for TdP for Development Compound Candidates? A Call to InvestigateRajesh Krishna
Journal of Clinical Pharmacology|August 22, 2006
Quantitative clinical pharmacology: Making paradigm shifts a realityRajesh Krishna
Journal of Clinical Pharmacology|November 27, 2025
Has Pharmacologic Contextualization Become a Lost Art? How Can We Revive the Integrator Pharmacologist?Rajesh Krishna
Pageof 10